BACKGROUND
A Vertebral Compression Fracture (VCF) occurs when the spinal vertebra collapses. VCF can lead to severe pain and deformity. It is the most common fracture in patients with osteoporosis.
The minimally invasive procedures for treating VCF today include vertebroplasty and kyphoplasty. In these procedures bone cement is injected through a hollow needle into the fractured vertebra to stabilize and strengthen the vertebra.
Acrylic bone cement consists of a liquid monomer and a copolymer powder which are mixed in the operating room. The mixture begins to harden while releasing toxic monomers. After waiting for the mixture to reach the right viscosity, surgeons have only a few minutes to inject the cement safely and accurately before it hardens inside the fractured vertebra.
Existing liquid/powder acrylic cements are plagued with limitations, including the release of toxic monomers, on-site mixing, cement inconsistent viscosity, and potential tissue damage due to exothermic reaction.
THE NOVEL BONE CEMENT FROM SETBONE
SetBone Medical introduces a new generation of acrylic bone cement that seeks to provide a safer and more efficient treatment.
SetBone’s proprietary acrylic bone cement does not contain any toxic monomers. It comes in a ready-to-use, prefilled cartridge and can be used right out of the box. No preparations required. The dual paste, mix on injection, allows extended working time. Its low exothermic reaction keeps the cement curing temperature low and prevents damage to surrounding tissue.
ADVANTAGES
No free toxic monomer
safe both for surgical team and patient
Ready-to-use
no need for on-site preparation
Low exothermic reaction
no polymerization heat; no damage to tissue
Same surgical approach
same procedure, same tools
